341 related articles for article (PubMed ID: 18849885)
1. Combined therapy (intratympanic dexamethasone + high-dose prednisone taper) for idiopathic sudden sensorineural hearing loss.
Rauch SD; Reda DJ
Otol Neurotol; 2009 Feb; 30(2):254-5; author reply 255-6. PubMed ID: 18849885
[No Abstract] [Full Text] [Related]
2. Side effects of oral dexamethasone pulse therapy for idiopathic sudden sensorineural hearing loss.
Free RH; Smale ND; de Kleine E; van der Laan BF
Otol Neurotol; 2009 Aug; 30(5):691. PubMed ID: 19503011
[No Abstract] [Full Text] [Related]
3. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
Battaglia A; Burchette R; Cueva R
Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic dexamethasone for refractory sudden sensorineural hearing loss.
Hunchaisri N; Chantapant S; Srinangyam N
J Med Assoc Thai; 2010 Dec; 93(12):1406-14. PubMed ID: 21344803
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic injection with dexamethasone for sudden sensorineural hearing loss.
Tsai YJ; Liang JG; Wu WB; Ding YF; Chiang RP; Wu SM
J Laryngol Otol; 2011 Feb; 125(2):133-7. PubMed ID: 21054907
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of sensorineural hearing loss in acute viral otitis media with intratympanic dexamethasone and hyaluronic acid in comparison with intravenous therapy].
Stenner M; Jecker P; Gouveris H; Mann W
Laryngorhinootologie; 2006 Jan; 85(1):32-7. PubMed ID: 16444653
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
9. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?
Ahn JH; Yoo MH; Yoon TH; Chung JW
Laryngoscope; 2008 Feb; 118(2):279-82. PubMed ID: 17989574
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic and systemic steroids for sudden hearing loss.
Koltsidopoulos P; Bibas A; Sismanis A; Tzonou A; Seggas I
Otol Neurotol; 2013 Jun; 34(4):771-6. PubMed ID: 23652330
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
[TBL] [Abstract][Full Text] [Related]
12. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E
Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
[TBL] [Abstract][Full Text] [Related]
13. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.
Tsounis M; Psillas G; Tsalighopoulos M; Vital V; Maroudias N; Markou K
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):103-110. PubMed ID: 29168028
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation.
Fu Y; Zhao H; Zhang T; Chi F
Auris Nasus Larynx; 2011 Apr; 38(2):165-71. PubMed ID: 20817429
[TBL] [Abstract][Full Text] [Related]
15. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
Westerlaken BO; de Kleine E; van der Laan B; Albers F
Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic injection of dexamethasone after failure of intravenous prednisolone in simultaneous bilateral sudden sensorineural hearing loss.
Tang B; Jia Y; Shi Z; Shen Y; Li D; Huang H; Yang B; Wang D; Feng Q
Am J Otolaryngol; 2018; 39(6):676-678. PubMed ID: 30032906
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic Triamcinolone Acetonide as Treatment Option for Idiopathic Sudden Sensorineural Hearing Loss.
Dahm V; Nieratschker M; Riss D; Kaider A; Auinger A; Honeder C; Arnoldner C
Otol Neurotol; 2019 Jul; 40(6):720-727. PubMed ID: 31192900
[TBL] [Abstract][Full Text] [Related]
18. In reference to Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy (Laryngoscope 119:359-369, 2009).
Nakashima T; Teranishi M; Yoshida T
Laryngoscope; 2009 Dec; 119(12):2480; author reply 2481-2. PubMed ID: 19688859
[No Abstract] [Full Text] [Related]
19. Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss.
Kakehata S; Sasaki A; Futai K; Kitani R; Shinkawa H
Audiol Neurootol; 2011; 16(3):191-7. PubMed ID: 20962524
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
Gouveris H; Selivanova O; Mann W
Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
